Skip to main content

Febbo Phillip G.

In the past year, 3 open-market sale filings worth $1.35M and no purchases.

Current role at each company

Open-market trades in the past year

Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.

Bought
–
0 filings
Sold
$1.35M
3 filings
Net
−$1.35M
Bought minus sold
Companies
1
With open-market trades

Trades

Every Form 4 that lists Febbo Phillip G. as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.

VCYT Veracyte, Inc.

Chief Scientific & Med Officer5 trades

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Sep 4, 2026 (view filing)7:54 PM ETSep 4Same dayFebbo Phillip G.Chief Scientific & Med OfficerSSale−13.1K$43.05−$564.4K−9.0%133.0K after2 lots10b5-1
Mar 4, 2026 (view filing)Mar 22 daysFebbo Phillip G.Chief Scientific & Med OfficerSSale−13.4K$36.16−$485.4K−10.3%117.3K after10b5-1
Oct 7, 2025 (view filing)Oct 61 dayFebbo Phillip G.Chief Scientific & Med OfficerSSale−8.35K$36.02−$300.7K−8.3%92.4K after10b5-1
Mar 6, 2025 (view filing)Mar 42 daysFebbo Phillip G.Chief Scientific & Med OfficerSSale−8.04K$33.34−$268.0K−8.9%82.5K after2 lots10b5-1
Dec 6, 2024 (view filing)Dec 42 daysFebbo Phillip G.Chief Scientific & Med OfficerSSale−3.93K$44.09−$173.5K−4.6%82.4K after10b5-1

ILMN Illumina, Inc.

SVP Chief Medical Officer2 trades

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Apr 7, 2022 (view filing)Apr 61 dayFebbo Phillip G.SVP Chief Medical OfficerSSale−1.99K$360.01−$715.7K−25.6%5.77K after
Nov 9, 2021 (view filing)Nov 81 dayFebbo Phillip G.SVP Chief Medical OfficerSSale−1.00K$406.83−$406.8K−24.9%3.02K after